Pfizer bid for AstraZeneca revives painful memories for Sweden
[at Financial Times] – After a slow start, public figures in Sweden – the other home market for AstraZeneca besides the UK – are starting to speak out against Pfizer’s $110bn bid for the Anglo-Swedish drugmaker. Politicians … more
View todays social media effects on PFE
View the latest stocks trending across Twitter. Click to view dashboard